Aster DM Healthcare Ltd. - Research Center
540975 ASTERDM Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 499.52 | 499.52 | 497.22 | 497.04 | 499.52 |
| Share application money | - | 6.51 | - | - | 10.76 |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 2,794.72 | 2,250.15 | 2,457.99 | 2,367.07 | 2,045.94 |
| Loan funds | |||||
| Secured loans | 386.64 | 714.36 | 197.81 | 153.79 | 514.59 |
| Unsecured loans | - | - | - | - | - |
| Total | 3,680.88 | 3,470.54 | 3,153.02 | 3,017.90 | 3,070.81 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 1,975.28 | 1,560.89 | 1,489.86 | 1,406.73 | 1,336.73 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 642.42 | 552.60 | 476.60 | 397.83 | 320.90 |
| Net block | 1,332.86 | 1,008.29 | 1,013.26 | 1,008.90 | 1,015.83 |
| Capital work-in-progress | 38.85 | 66.55 | 22.91 | 10.90 | 20.15 |
| Investments | 2,175.55 | 2,141.10 | 2,166.03 | 2,150.65 | 2,150.42 |
| Net current assets | |||||
| Current assets, loans & advances | 990.47 | 886.13 | 559.80 | 418.17 | 366.60 |
| Less : current liabilities & provisions | 856.85 | 631.53 | 608.98 | 570.72 | 482.19 |
| Total net current assets | 133.62 | 254.60 | -49.18 | -152.55 | -115.59 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 3,680.88 | 3,470.54 | 3,153.02 | 3,017.90 | 3,070.81 |
| Notes: | |||||
| Book value of unquoted investments | 1,439.36 | 2,141.10 | 2,166.03 | 2,150.65 | 2,150.42 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 206.11 | 490.33 | 397.24 | 323.87 | 248.00 |
| Number of equity sharesoutstanding (Lacs) | 4995.00 | 4995.00 | 4972.00 | 4970.40 | 4995.20 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis